JP3623150004
JP3623150004
TOWA PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 273.710.000.000 | 259.594.000.000 | 5.4% |
| Cost of Revenue | 174.606.000.000 | 164.865.000.000 | 5.9% |
| Gross Profit | 99.104.000.000 | 94.729.000.000 | 4.6% |
| 76.001.000.000 | 71.486.000.000 | 6.3% | |
| Operating Income | 23.103.000.000 | 23.243.000.000 | 0.6% |
| Pretax Income | 13.165.000.000 | 26.330.000.000 | 50.0% |
| Net Income Common Stockholders | 5.250.000.000 | 18.986.000.000 | 72.3% |
| -- | -- | -- | |
| -- | -- | -- |